Latest Biotech News

10x Genomics used the AACR meeting circuit to launch Atera, a new spatial instrument aimed at whole-transcriptome profiling at scale. The company positioned Atera as closing performance gaps seen...

Revolution Medicines’ latest Phase 3 pancreatic cancer result pushed the company back into acquisition focus, with reporting that the market valuation and deal appetite shifted after the survival...

Gene therapy’s growing clinical footprint drew another spotlight as the Breakthrough Prize Foundation handed the Life Sciences prize to two pioneering teams. One effort, led by...

FDA’s Pharmacy Compounding Advisory Committee is set to convene July 23–24 to consider whether seven peptides used for unproven indications should be added to products that can be compounded. The...

Roche outlined a new strategy to support EMA approval for Elevidys (delandistrogene moxeparvovec), signaling it will pursue additional global Phase 3 evidence for Duchenne muscular dystrophy. The...

Neomorph raised $100 million in a Series B to push its molecular glue degrader NEO-811 through an ongoing Phase I/II trial in clear cell renal cell carcinoma. The company’s approach targets ARNT...

Alamar Biosciences began trading on Nasdaq under ticker ALMR after pricing its initial public offering at $17 per share, raising roughly $220 million in gross proceeds. The proteomics company...

Kailera Therapeutics priced an upsized IPO raising $625 million, positioning the offering as a record-setting debut for U.S. biotech. The company plans to use the proceeds to fund global clinical...

Researchers reported wastewater-based epidemiology that can detect the emergence of clinically significant and drug-resistant Candida auris strains within healthcare settings. The work, attributed...

At AACR, Ultima Genomics presented early TRACERx MRD results using its ppmSeq technology, describing ultra-sensitive ctDNA detection in plasma at low single-digit parts-per-million. The program is...

Researchers led by Chang, Moshi, Nguyen and colleagues reported in Nature Communications (2026) that wastewater-based epidemiology can detect clinically significant, drug-resistant Candida auris...

A 20-year cohort study reported that metabolically healthy obesity (MHO) is still associated with substantial cardiovascular risk over time. The findings shift the narrative from “metabolically...

Researchers in Gene Therapy reported that adenine base editing can rescue a cryptic splice mutation in cardiac Fabry disease–relevant cells. The study details correction of an IVS4+919 G>A...

Three gene therapy pioneers behind the first U.S.-approved gene therapy received the Breakthrough Prize in Life Sciences, recognizing foundational work that helped move gene transfer from concept...

A clinical trial reported in the journal Nature-backed release indicates regulatory dendritic cells (DCreg) can enable earlier withdrawal of standard immunosuppressive drugs in living-donor liver...

Roche announced a further global Phase III trial route for its Duchenne muscular dystrophy gene therapy Elevidys (delandistrogene moxeparvovec) as it seeks EMA approval progress. The company said...

Kailera Therapeutics priced an upsized IPO, raising $625 million to fund clinical development of obesity drugs, according to the company’s public offering terms. The deal sets a new benchmark for...

Biopharma investment activity showed a mix of workforce and funding signals, with fewer layoffs than the prior year but a still-elevated number of affected employees. In Q1 2026, BioSpace tallies...

Neomorph secured a $100 million Series B financing to advance NEO-811, an oral molecular glue degrader designed to degrade ARNT (HIF-1β) in clear cell renal cell carcinoma. The financing led by...

Takara Bio and Resistomap expanded a partnership to develop high-throughput antimicrobial resistance surveillance products using environmental samples. The companies combined Takara Bio’s...